按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Hepatology (2024)
WOS
0
0
Gastroenterologyno. 5 (2024): S-1603-S-1604
0
0
Journal of Hepatology (2024)
WOS
0
0
Infekcionnye boleznino. 2 (2024): 13-21
0
0
P135 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301 (2024)
0
0
NEW ENGLAND JOURNAL OF MEDICINE (2024)
0
0
Journal of hepatology (2024): S758-S758
0
0
P134 Efficacy and safety of 48-week off-therapy of Bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta final results from the phase 2b, open-label, randomised, multicentre study MYR204 (2024)
0
0
加载更多